openPR Logo
Press release

Proteomics Market worth $72.9 billion by 2028 | Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Merck KGaA (Germany)

06-27-2023 12:28 PM CET | Health & Medicine

Press release from: marketsandmarket

Proteomics Market

Proteomics Market

The report "Proteomics Market by Product (Spectroscopy, Chromatography, Electrophoresis, X-Ray Crystallography), Reagent, Service, (Core Proteomics, Bioinformatics), Application (Diagnostic, Drug Discovery), End User (Hospital, Labs, Biopharma) - Global Forecasts to 2028", size is projected to reach USD 72.9 billion by 2028 from 36.8 billion in 2023, at a CAGR of 14.6% during the forecast period.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=731&utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral

Factors such as increasing investments in the development of structure-based drug design, growing research in the field of omics, rising demand for high-quality research tools for data reproducibility, and increasing focus on developing personalized therapeutics are driving the growth of this market. However, challenges associated with data management are the major factors restraining the growth of this market.

Spectroscopy accounted for the largest share of the instrumentation technologies segment in the proteomics market in 2022.

Based on instrumentation technologies, the proteomics market is broadly segmented into spectroscopy, chromatography, electrophoresis, protein microarrays, X-ray crystallography, surface plasmon resonance, protein fractionation, and other technologies. In 2022, spectroscopy accounted for the largest share of the proteomics market for instrumentation technologies. This segment's large share can be attributed to factors such as being widely utilized for studying proteins, their structures, interactions, and functions. Spectroscopic techniques provide valuable insights into the properties of proteins, including their secondary and tertiary structures, conformational changes, and ligand binding.

Mass spectrometry technology accounted for the largest share of the type segment in the proteomics market in 2022.

Based on type, spectroscopy instrumentation technology is categorized into three sub-segments- mass spectrometry (MS), NMR spectroscopy, and circular dichroism (CD) spectroscopy. In 2022, mass spectrometry accounted for the largest share of the spectroscopy instrumentation technology segment. Factors such as the MS can analyze large numbers of samples in a short period of time, making it ideal for large-scale proteomics studies is attributed to its large share.

Gel electrophoresis technology accounted for the largest share of the type segment in the proteomics market in 2022.

Based on type, electrophoresis instrumentation technology is categorized into two sub-segments- Gel and capillary electrophoresis. In 2022, gel electrophoresis accounted for the largest share of the electrophoresis instrumentation technology segment. Factors such as the increasing demand for gel electrophoresis in proteomics research and personalized medicine is a major factors driving the growth of the overall gel electrophoresis market.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=731&utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral

Asia Pacific is likely to grow at the highest growth rate during the forecast period.

Based on the region The global proteomics market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America is the largest regional segment. The Asia Pacific region is estimated to grow at the highest CAGR in the proteomics market during the forecast period. The growth of the pharmaceuticals and life sciences market in the region is primarily driven by the rising prevalence of chronic disease conditions, the rising R&D expenditure, especially in the area of drug discovery & development, and significant investments in the development of therapeutics mAbs.

Key Market Players

Some of the prominent players in the proteomics market are Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), and Waters Corporation (US) and among others.

Recent Developments:

In February 2023, Waters Corporation acquired Wyatt Technology, which enhances the portfolio of Separation and Detection, which provides customers with an unmatched set of analytical solutions across a wide range of applications.

In October 2022, Agilent Technologies Inc. and CMP Scientific Corp. entered into a co-marketing agreement to provide an integrated capillary electrophoresis-mass spectrometry (CE-MS) solution for the life science and pharmaceutical industries.

In November 2021, Thermo Fisher Scientific acquired Belgium-based Pharmafluidics, the developer of the μPAC range of micro-chip-based chromatography columns. The µpac portfolio of columns enhances liquid chromatography (lc) performance in biomarker, proteomics, and drug r&d applications, helping biotechnology and pharmaceutical companies uncover new insights and advance scientific discovery.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=731&utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/proteomic-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/proteomics.asp

About MarketsandMarkets™:

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Proteomics Market worth $72.9 billion by 2028 | Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Merck KGaA (Germany) here

News-ID: 3103849 • Views:

More Releases from marketsandmarket

Vaccines Market worth $93.8 billion by 2028
Vaccines Market worth $93.8 billion by 2028
Vaccines Market in terms of revenue was estimated to be worth $77.6 billion in 2023 and is poised to reach $93.8 billion by 2028, growing at a CAGR of 3.9% from 2023 to 2028 according to a new report by MarketsandMarkets. The global vaccines market is expected to grow at a CAGR of 3.9% during the forecast period. The growth of the market is projected to be driven by factors such
Bioimpedance Analyzers Market worth $927 million by 2028
Bioimpedance Analyzers Market worth $927 million by 2028
Bioimpedance Analyzers Market in terms of revenue was estimated to be worth $564 million in 2023 and is poised to reach $927 million by 2028, growing at a CAGR of 10.4% from 2023 to 2028 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by rising initiatives by government in promoting healthy lifestyle to curb obesity, growing number of gyms and wellness centers, strong
Global Livestock Monitoring Market Share To worth USD 3.7 billion by 2030 | CAGR of 11.0%
Global Livestock Monitoring Market Share To worth USD 3.7 billion by 2030 | CAGR …
The global livestock monitoring market in terms of revenue was estimated to be worth USD 1.6 billion in 2022 and is poised to reach USD 3.7 billion by 2030, growing at a CAGR of 11.0% from 2022 to 2030. The new research study consists of an industry trend analysis of the market. The report profiles key players such as Allflex Livestock Intelligence (Subsidiary of MSD Animal Health) (US), DeLaval (Sweden), Afimilk
Intraoral/IOL Scanners Market worth $1.0 billion | DENTSPLY SIRONA Inc (US), 3Shape (US), Envista Holdings Corporation (US), Medit Corp. (South Korea), and Align Technology Inc. (US)
Intraoral/IOL Scanners Market worth $1.0 billion | DENTSPLY SIRONA Inc (US), 3Sh …
Intraoral/IOL Scanners Market in terms of revenue was estimated to be worth $0.6 billion in 2023 and is poised to reach $1.0 billion by 2028, growing at a CAGR of 11.0% from 2023 to 2028 according to a new report by MarketsandMarkets™. Developing countries such as China, India, Mexico, Brazil, New Zealand, the Middle East, and other APAC and Latin American countries present a lucrative opportunity for players in the

All 4 Releases


More Releases for Proteomics

Selected Reaction Monitoring Market: MRM Proteomics, Sigma-Aldrich, Thermo Fishe …
Selected Reaction Monitoring Market research report provides valuable insights by analyzing market trends and market scenarios over a defined period. It also presents manufacturing details like sales, volume, revenue, price, and gross margin. Furthermore, the import-export analysis and pricing analysis are also included in the report to understand the product demand and service. Finally, it also provides end-user application analysis, which delivers revenue, and a growing percentage of the product
Rising R&D Investments in Proteomics promote the Global Proteomics Market Growth
According to a new market research report launched by Inkwood Research, the Global Proteomics Market is projected to register a CAGR of 14.24% during the forecast period, and generate net revenue of $91.52 billion by 2030 Browse 83 Market Data Tables and 62 Figures spread over 200 Pages, along with an in-depth analysis of the Global Proteomics Market by Components, Application, & by Geography. This insightful market research report by Inkwood Research
Selected Reaction Monitoring Market to Witness Huge Growth by Key Players: MRM P …
ReportsnReports publishes the report titled Selected Reaction Monitoring that presents a 360-degree overview of the market under one roof. The report is developed with the meticulous efforts of an enthusiastic and experienced team of experts, analyts, and researchers that makes the report a valuable asset for stakeholders to make robust decisions. This report also provides an in-depth overview of product type, specification, technology, and production analysis considering vital factors like
Proteomics Market: Opportunities & Challenges
The Global Proteomics Market is projected to reach USD 38.74 billion by 2024 from USD 19.49 billion in 2019, at a CAGR of 14.7% during the forecast period. An increase in the research activity, especially in the area of personalized medicine and drug discovery is the primary growth driver for this market. In addition, the increasing R&D expenditure by pharmaceutical and biotechnology companies, increasing government funding, and technological advancements are
Global Selected Reaction Monitoring Market 2019 Top Key Players: MRM Proteomics, …
Summary WiseGuyReports.com adds “Selected Reaction Monitoring Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024” reports to its database. This report provides in depth study of “Selected Reaction Monitoring Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Selected Reaction Monitoring Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an
Protein Fractionation Market to be Driven by Increase in the Proteomics Activiti …
Protein fractionation referred as a process of separation or purification of single or multiple proteinfrom complex mixture of protein based on differences in a specific property of individual component. It is a major step in Proteomics, which is a science of protein analysis. Key limitation of protein and peptide analysis is their heterogenicity in terms of their physiochemical properties. Hence, the protein fractionation technique is very useful tool for protein